维普中文期刊产品整合服务
51篇 您的检索式:作者名="VENOOK A"
    题名 作者 年代 出处 被引量
1Phase Ⅲ study of irinotecan/5FU/LV (FOLFIRI)or oxaliplatin/5FU/LV (FOLFOX)-+-cetuximab for pa- tients with untreated metastatic adenocarcinoma ofthe colon or rectum (MCRC): CALGB 80203 pre- liminary results显示文摘VENOOK A NIEDZWIECKI D HOLLIS D 2006Journal of Clinical Oncology2006,24,18:1
2Critical evaluation of current treatments in metastatic colorectal cancer 显示文摘Venook A 2005Oncologist2005,10,4:1
3NCCN Clinical Practice Guidelines in Oncology:rectal cancer 显示文摘Engstrom PF Arnoletti JP Benson AB 3rd Chen YJ Choti MA Cooper HS Covey A Dilawari RA Early DS Enzinger PC Fakih MG Fleshman J Jr Fuchs C Greta JL Kiel K Knol JA Leong LA Lin E Mulcahy MF Rao S Ryan DP Saltz L Shibata D Skibber JM Sofocleous C Thomas J Venook AP Willett C 2009J Natl Compr Canc Netw2009,7,:1
4Phase Ⅲ study of irinotecan/ 5-FU/ LV (FOLFIRI) or oxaliplatin/ 5-FU/ LV (FOLFOX) + cetuximab for patients ( pts ) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC) : CALGB 80203 preliminary results 显示文摘VENOOK A NIEDZWIECKI D HOLLIS D 2006J Clin Oncol2006,24,18:1
5Shedding of paradigms:developing virus to treat cancer显示文摘Bergsland E K Venook A P 2002J Clin Oncol2002,20,:1
6Phase II study of irinotecanl5-FU/LV (FOLFIRI) or oxaliplatinl5-FUI LV (FOLFOX) ± cetuximab for patients with untreated metastatic adenocarcinoma of the colon or rectum ( MCRC): CALGB80203 preliminary results 显示文摘Venook A Niedzwiecki D Hollis D 2006J Clin Oncol2006,24,18:1
7A Phase Ⅱ study of ANGIOZYME in combination with 5-fluorouracil,leucovorin and irinotecan in the treatment of metastatic colorectal cancer patients显示文摘Usman N Venook A Hurwttz H 2002Eur J Cancer2002,38,7:1
8Hepatocellular carcinoma: Ablate and wait versus rapid transplantation显示文摘Roberts JP Venook A Kerlan R 2010Liver Transpl2010,16,8:1
9Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial显示文摘Mulvihill S Warren R Venook A 2001Gene Ther2001,8,4:1
10Hepatocellular carcinoma:Epidemic and treatment显示文摘Allen J Venook A 2004Curr Oncol Rep2004,6,3:1
11Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial显示文摘 Warren R Venook A 2001Gene Ther2001,8,4:1
12Reactivation of hepatitis C virus after chemotherapy for colon cancer 显示文摘Melisko ME Fox R Venook A 2004Clin Oncol (R Coll Radiol2004,16,30:1
13Safety and feasibility of injection with an E1B-55 kDa gene-deleted,replication-selective adenovirus(ONYX-015)into primary carcinomas of the pancreas:a phase Ⅰ trial显示文摘Mulvihill S Warren R Venook A 2001Gene Ther2001,8,4:1
14Targeted therapy in colorectal cancer显示文摘Rajpal S Venook A P 2006Clin Adv Hematol Oncol2006,4,2:1
15Safety and feasibility of injection with an E1B-55 kDa gene-deleted,replicationselective adenovirus (ONYX-015 ) into primary carcinomas of the pancreas:a phase I trial 显示文摘Mulvihill S Warren R Venook A 2001Gene Ther2001,8,4:1
16Phase ill study of irinotecan + 5-FU/LV (FOLFIRI) or oxaliplatin + 5-FU/LV (FOLFOX) ± cetuximab for patients with untreated metastatic adenocarcinoma of colon and rectal cacer (MCRC): CALGB80203 primary results (abst) 显示文摘Venook A Niedzwiecki D Hoillis D et a1 2006Pro Am Soc Clin Oncol2006,,:1
17Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial显示文摘 Warren R Venook A 2001Gene Ther2001,8,4:1
18Phase Ⅲ study of irinotecart/5FU/LV (FOLFIRI) or oxaliplatin/5-FU/ LV (FOLFOX) + cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum ( MCRC ) : CALGB 80203 preliminary resuits 显示文摘Venook A Niedzwiecki D Hollis D 2006Proc Am Soc Clin Oncol2006,24,18:1
19critical evaluation of current treatment in metastatic colorectal Cancer显示文摘Venook A 2005Oncologist2005,10,4:1
20Current treatments for metastatic colorectal cancer显示文摘Venook A 2005Oncologist2005,10,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费